Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
microbiome
Biotech
Seres to lay off 30% of employees, pause lead program
Just months after laying off a quarter of its workforce, Seres is sending more employees to the exits.
James Waldron
Feb 12, 2026 9:55am
Vedanta ‘significantly’ reduces headcount to fund lead program
Jan 16, 2026 11:05am
Seres shrinks head count by 25% to fund biotherapeutic's ph. 2
Sep 23, 2025 10:00am
Vedanta's live bacteria cocktail fails phase 2 colitis trial
Aug 13, 2025 1:48pm
Fecal transplants alleviate fibromyalgia pain in small trial
Apr 28, 2025 7:30am
Vaccine-probiotic combo clears gut infections in mice
Apr 9, 2025 5:25am